HotSpot Therapeutics
hotspotthera.com
Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
201-500
employees, estimated range
Backers
2
Atlas Venture, Sofinnova Partners
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Atlas Venture 
Sofinnova Partners Similar startupsby what they do, their industry and backers
Correctors and Potentiators for Autosomal Dominant Polycystic Kidney Disease (ADPKD). Transforming the Treatment of ADPKD.
On a mission to transform the future of autoimmune care. Developing innovative therapies with the potential to redefine the standard of…
Harnessing the power of allosteric modulators to design targeted, next-generation therapies for complex neuropsychiatric disorders.
Committed to developing high-impact and differentiated therapies, with a focus on building a robust autoimmune disease and cancer pipeline…
Kymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation.
Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology.
Overview
Pioneering a new class of allosteric medicines for the treatment of autoimmune disease. At HotSpot Therapeutics, we are pioneering a new approach to allosteric drug discovery by unlocking the on/off switches on proteins called "natural hotspots" to enable differentiated medicines for patients.